Results 11 to 20 of about 8,409 (203)

Recent progress of methods for cuproptosis detection [PDF]

open access: yesFrontiers in Molecular Biosciences
Varying from other identified cell death pathways, cuproptosis is a new type of regulated cell death characterized by excess Cu ions, abnormal aggregation of lipoylated proteins in TCA cycle, loss of Fe-S cluster proteins, upregulation of HSP70, leading ...
Ligang Zhang   +11 more
doaj   +2 more sources

Chirality‐Directed Strategy to Overcome Tumor Resistance to Cuproptosis and Enhance Cuproptosis‐Immunotherapy

open access: yesSmall Structures
Cuproptosis, a recently identified copper‐dependent metabolic cell death pathway, eliminates tumor cell via toxic aggregation of lipoylated enzymes in the tricarboxylic acid cycle.
Hao Zhou   +8 more
doaj   +2 more sources

Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis [PDF]

open access: yesFrontiers in Molecular Biosciences, 2023
Cuproptosis is a novel form of cell death linked to mitochondrial metabolism and is mediated by protein lipoylation. The mechanism of cuproptosis in many diseases, such as psoriasis, remains unclear.
Qingyuan Lin   +6 more
doaj   +2 more sources

Cuproptosis in stroke: focusing on pathogenesis and treatment [PDF]

open access: yesFrontiers in Molecular Neuroscience
Annually, more than 15 million people worldwide suffer from stroke, a condition linked to high mortality and disability rates. This disease significantly affects daily life, impairing everyday functioning, executive function, and cognition.
Liwei Xing   +5 more
doaj   +2 more sources

Enhanced strategies for cuproptosis‐like death in bacterial infection treatment

open access: yesBMEMat
Copper, a classical antibacterial metal, has long been of interest and widely used in medical and public health applications. Recent findings that copper can induce programmed cell death (cuproptosis) not only in eukaryotes but also in bacteria ...
Wenqi Wang   +7 more
doaj   +2 more sources

SOX2 Inhibits Cuproptosis to Affect Cisplatin Resistance in Non-Small Cell Lung Cancer by Activating the Wnt/ATP7B Signaling Pathway. [PDF]

open access: yesKaohsiung J Med Sci
ABSTRACT Cisplatin (CDDP) resistance constitutes the principal clinical challenge in the treatment of advanced non‐small cell lung cancers (NSCLC). Disturbances in copper metabolism are closely linked with tumor drug resistance. SOX2, a pivotal stemness transcription factor (TF), holds an important role in chemotherapy resistance.
Chen K   +5 more
europepmc   +2 more sources

Reversing Temozolomide Resistance in Glioblastoma Based on Cuproptosis-Mediated Positive Feedback Loop. [PDF]

open access: yesAdv Sci (Weinh)
To effectively reverse TMZ resistance, this work proposes a cuproptosis‐mediated positive feedback loop that integrates mitochondrial dysfunction, ATP depletion, AMPK‐p53 signaling, and glycolytic inhibition, ultimately amplifying cell death. This cuproptosis‐mediated feedback loop simultaneously disrupts multiple resistance pathways in GBM, including ...
Feng W   +9 more
europepmc   +2 more sources

Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer

open access: yesFrontiers in Immunology, 2022
Cuproptosis is a novel copper ion-dependent cell death type being regulated in cells, and this is quite different from the common cell death patterns such as apoptosis, pyroptosis, necroptosis, and ferroptosis.
Qiang Song   +4 more
doaj   +1 more source

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma

open access: yesEuropean Journal of Medical Research, 2023
Objective The latest research proposed a novel copper-dependent programmed cell death named cuproptosis. We aimed to elucidate the influence of cuproptosis in clear cell renal cell carcinoma (ccRCC) from a multi-omic perspective.
Maoshu Zhu   +5 more
doaj   +1 more source

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma

open access: yesFrontiers in Immunology, 2022
BackgroundThough immune checkpoint inhibitors (ICIs) exhibit durable efficacy in bladder carcinomas (BLCAs), there are still a large portion of patients insensitive to ICIs treatment.MethodsWe systematically evaluated the cuproptosis patterns in BLCA ...
Huihuang Li   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy